CIK: 1681782 - Address: C/O Allovir, Inc., 1100 Winter Street, Waltham, MA 02451
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/23/24 16:15
4/19/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS.m-10.75030-1-178D
4/4/24 16:15
4/2/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS00.772000079D
2/22/24 16:15
2/20/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS00.695200-179D
2/9/24 20:01
2/8/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-70.67210-11-1279D
2/6/24 16:39
2/5/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-40.67000-6-690D
1/25/24 16:15
1/23/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-10.67080-1-196D
1/8/24 16:15
1/4/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS00.639000097D
1/2/24 19:36
12/27/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-210.73540-28-2398D
11/21/23 17:00
11/17/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-11.63000126D
10/23/23 17:00
10/19/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS.m-11.560-1-1126D
10/5/23 17:00
10/3/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS01.98000127D
8/21/23 17:00
8/17/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-42.500-2-1127D
7/21/23 17:00
7/19/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS.m-23.450-1-1129D
6/13/23 17:00
6/9/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-285.640-5-4130D
4/21/23 16:05
4/19/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS.m-33.670-1-1135D
1/23/23 19:00
1/19/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS.m-105.090-2-274D
11/14/22 17:06
11/10/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS.m-1958.130-24-2476D
10/26/22 16:15
10/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS.a-39.36000113D
10/24/22 18:25
10/19/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS.m-1158.430-14-12100D
4/22/22 08:20
4/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-26.6800080D
1/24/22 16:15
1/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-148.750-2-263D
2/23/21 19:43
2/22/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-3543.140-1-165D
2/19/21 08:44
2/18/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS-3040.110-1-166D
2/18/21 21:18
2/16/21
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagHagen Brett RMAOChief AcS.m-22241.260-5-766D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact